SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $957,327 | -17.4% | 20,360 | +221.5% | 0.13% | -15.7% |
| Q2 2019 | $1,159,000 | -39.3% | 6,332 | -68.2% | 0.16% | +6.0% |
| Q4 2018 | $1,908,000 | +271.2% | 19,922 | +447.0% | 0.15% | +150.0% |
| Q3 2018 | $514,000 | -35.7% | 3,642 | -28.6% | 0.06% | -40.0% |
| Q2 2018 | $799,000 | +0.6% | 5,102 | +3.5% | 0.10% | -3.8% |
| Q1 2018 | $794,000 | -25.0% | 4,929 | -23.4% | 0.10% | -25.7% |
| Q4 2017 | $1,059,000 | +149.2% | 6,431 | -5.8% | 0.14% | +141.4% |
| Q3 2017 | $425,000 | -83.1% | 6,826 | -78.4% | 0.06% | -83.9% |
| Q2 2017 | $2,521,000 | +14.9% | 31,660 | +2.5% | 0.36% | +4.9% |
| Q1 2017 | $2,194,000 | +268.1% | 30,873 | +164.6% | 0.34% | +251.0% |
| Q4 2016 | $596,000 | – | 11,669 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |